LifeMD Overhauls Leadership Team with CFO, CMO, and CBO Appointments
Event summary
- LifeMD appointed Atul Kavthekar as CFO on March 16, 2026, replacing Marc Benathen, who departs March 31, 2026.
- Kavthekar received 675,000 restricted stock units, with 337,500 tied to performance targets.
- Chris Pisano joined as Chief Marketing Officer, and Jessica Friedeman became Chief Business Officer.
- Kavthekar brings 30 years of healthcare finance experience, focusing on AI-driven transformation.
The big picture
LifeMD’s leadership overhaul signals a strategic pivot toward AI-driven healthcare, aiming to improve patient access and operational efficiency. The appointments of Kavthekar, Pisano, and Friedeman reflect a push for scalable growth, capitalizing on the telemedicine boom and expanding enterprise health offerings. The company’s focus on financial and technological infrastructure underscores its ambition to lead in virtual primary care.
What we're watching
- AI Integration
- How Kavthekar’s financial leadership will accelerate LifeMD’s AI-first healthcare vision.
- Growth Strategy
- Whether the new leadership team can sustain LifeMD’s expansion in enterprise and employer health.
- Operational Efficiency
- The pace at which LifeMD can reduce operational overhead through AI and financial infrastructure.
Related topics